We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Prognostic Value of Blood Cell Counts Investigated

By LabMedica International staff writers
Posted on 29 Oct 2018
The prognosis and treatment of gastric cancer patients after radical gastrectomy mainly depends on classification of malignant tumors (TNM) stage system. More...
However, the prognosis of gastric cancer patients could be various even with the same tumor stage.

Over the past decades, prognostic value of blood test parameters in gastric cancer patients has been investigated by numerous studies, because a blood test is simple, convenient, reproducible and cost-effective. However, the most common parameters been investigated in the previous reports were neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR).

Medical scientists at the Fourth Military Medical University (Xi’an, China) enrolled a total of 3,243 gastric cancer patients from September 2008 to March 2015. There were 2,538 male and 705 female and the median age was 58 years (range 20–90). The median follow-up time was 24.9 months (range 1–75). All patients were treated with radical D2 gastrectomy, defined as a dissection of all the Group 1 and Group 2 nodes, and regular follow up.

Preoperative blood test was performed within seven days before surgery. Absolute count of white blood cells or leukocytes (WBC), neutrophil, lymphocyte, monocyte and platelet were recorded. Patients with signs of infection were excluded. Clinicopathological data including gender, age, tumor location, tumor size, pathological type, tumor depth, lymph node metastasis and tumor stage were collected. The patients were followed up until November 2015 every three months.

The team reported that the statistically significant optimal cut off value was 6.19 × 109/L for WBC, 4.19 × 109/L for neutrophils, 1.72 × 109/L for lymphocytes, 0.51 × 109/L for monocytes, and 260 × 109/L for platelets, respectively. Neutrophil, lymphocyte, monocyte and platelet were risk factors for the prognosis of gastric cancer. However, only lymphocyte and monocyte were independent risk factors. Combination of lymphocyte and monocyte counts could increase the prognostic value for gastric cancer patients, especially in stage II/III gastric cancer patients.

The authors concluded that absolute count of blood cells was more convenient in predicting the prognosis of gastric cancer patients. High absolute count of neutrophil, monocyte and platelet, and low absolute count of lymphocyte were associated with poor prognosis of gastric cancer. However, only lymphocyte and monocyte count were independent prognostic predictors. The study was published on October 11, 2018, in the journal BMC Gastroenterology.

Related Links:
Fourth Military Medical University


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.